Pharmaceutical Ingredients Telmisartan 144701-48-4 99% Purity Telmisartan Antihypertensive Telmisartan

• CAS No.: 144701-48-4
• Formula: C33h30n4o2
• EINECS: /
• Type: Agrochemical Intermediates
• Appearance: Powder
• Quality: Industrial
• Model NO.: D-Sung Telmisartan
• Colour: White
• Product Name: Telmisartan
• Name: Telmisartan Powder
• Molecular Formu: C33h30n4o2
• Color: White
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Agriculture
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• Logp: 7.26440
• Melting Point: 771.9ºC at 760mmhg
• Flashing Point: 420.6
• Psa: 72.94000
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-Sung
• Origin: Xi′an Shaanxi
• Production Capacity: 100kg/Month

Product Description

Pharmaceutical Ingredients Telmisartan 144701-48-4 99% Purity Telmisartan Antihypertensive Telmisartan
 

Product Description

 

Product Details

 

Product name	Telmisartan
Purity	99%
Appearance	White Crystalline powder
CAS NO	144701-48-4
Molecular Formula	C33H30N4O2
Shelf life	2 years

Telmisartan tablets, hypertension for the treatment of essential hypertension in adults. Reduce cardiovascular risk. This product is suitable for age 55 and above. To reduce the incidence of myocardial infarction in patients who are at high risk for serious cardiovascular events and cannot be treated with ACE inhibitors. Risk of death from stroke or cardiovascular disease. The high risk of cardiovascular events includes coronary artery disease. History of high-risk type 2 diabetes (insulin-dependent or non-insulin-dependent) with peripheral artery disease, stroke, transient ischemic attack, or evidence of end-organ damage. Telmisartan can also be used in conjunction with other necessary treatments (such as blood pressure medications). Antiplatelet agents or lipid-lowering agents).

Application&Function

 

Telmisartan tablets, hypertension for the treatment of essential hypertension in adults. Reduce cardiovascular risk. This product is suitable for age 55 and above. To reduce the incidence of myocardial infarction in patients who are at high risk for serious cardiovascular events and cannot be treated with ACE inhibitors. Risk of death from stroke or cardiovascular disease. The high risk of cardiovascular events includes coronary artery disease. History of high-risk type 2 diabetes (insulin-dependent or non-insulin-dependent) with peripheral artery disease, stroke, transient ischemic attack, or evidence of end-organ damage. Telmisartan can also be used in conjunction with other necessary treatments (such as blood pressure medications). Antiplatelet agents or lipid-lowering agents).